COVID-19 Antibodies – R&D Samples Available

Published: 17.09.2020
17 Sep, 2020
HyTest Live Webinar - Diagnostics of COVID-19: Achievements, Challenges and Perspectives

By attending this webinar, you will learn about:
- transmission and clinical characteristics of SARS-CoV-2
- the existing testing methods for SARS-CoV-2, including nucleic acid testing, genome sequencing, serological testing for SARS-CoV-2 specific antibodies and antigen testing
- the principles, advantages and limitations of these testing methods
- safety precautions for handling different types of clinical specimens for SARS-CoV-2 detection

Read more
26 Aug, 2020
New Product! SARS-CoV-2 Nucleoprotein

HyTest’s SARS-CoV-2 Nucleoprotein (Cat.# 8COV3) is a full-length recombinant antigen that can be used in serology assays for the detection of COVID-19 specific antibodies.

Read more
26 Aug, 2020
New Product! ST2 Antibodies and Antigen

Soluble ST2 (sST2) biomarker is used for additive risk stratification and prognosis of patients with heart failure (HF). ST2 interacts with IL-33, and IL-33/ST2 system is upregulated in cardiomyocytes and fibroblasts in response to cardiac injury or cardiac stress.

Read more
11 Jul, 2020
New Product! SARS-CoV-2 Spike RBD Antigen

HyTest’s recombinant SARS-CoV-2 Spike RBD is now available. The antigen can be used in the development of COVID-19 serology (antibody) tests.

Read more
02 Jul, 2020
SARS-Cov-2 Nucleoprotein – R&D Samples Available

We are finalizing the development of SARS-CoV-2 Nucleoprotein. The antigen can be used in serology assays.

Read more
25 Jun, 2020
New Product: Recombinant GFAP

We have now developed a recombinant GFAP protein that can be used as a standard or calibrator in GFAP immunoassay development

Read more
24 Jun, 2020
New Article: CT-IGFBP-4 as a Novel Prognostic Biomarker in Acute Heart Failure

Insulin-like growth factor binding protein-4 (IGFBP-4) fragments have been shown to predict the risk of major adverse cardiovascular events, including segment-elevation myocardial infarction, in patients with acute coronary syndrome.

Read more
02 Jun, 2020
SARS-Cov-2 Recombinant Antigen – R&D Samples Available

We are finalizing the development of SARS-Cov-2 Spike RBD recombinant antigen.

Read more
27 May, 2020
New! Polyclonal Antibodies Specific to Canine CRP

In dogs, C-reactive protein (CRP) can be used as a marker of inflammation. Its concentration in blood increases rapidly in systemic inflammation and decreases quickly during recovery. It has been shown to increase in disorders such as bacterial infections, sepsis and pyometra, as well as in the case of post-surgical infections.

Read more
27 May, 2020
Winner of the 2020 IFCC Distinguished Award for Contributions to Cardiovascular Diagnostics

Prof. Fred S. Apple (Hennepin Healthcare/Hennepin County Medical Center, Laboratory Medicine and Pathology, and University of Minnesota School of Medicine, Minneapolis MN, US) is the winner of the 2020 IFCC Distinguished Award for Contributions to Cardiovascular Diagnostics, sponsored by HyTest. This award honors an individual who has undertaken remarkable scientific work with cardiac markers or immunodiagnostic applications to improve cardiac disease diagnosis.

Read more
27 May, 2020
Meet HyTest China Team at CACLP Expo

We will attend the 17th China Association of Clinical Laboratory Practice Expo held at Nanchang Greenland International Expo Center, on 21-23 August.

Read more
29 Apr, 2020
New Product! Recombinant Rabbit Cardiac Troponin I Antibodies Targeted to Epitope Region 24-40

The cardiac isoform of Troponin I (cTnI) is used as a gold standard as marker of acute myocardial infarction (AMI). The region 24-40 aar of cTnI is a perspective target for monoclonal antibodies (MAb), because it is less affected by the action of autoantibodies and is not hindered by the other components of troponin complex.

Read more
16 Apr, 2020
HyTest Live Webinar - COVID-19: Biomarkers to Distinguish Severity and Prognosis

By watching this webinar, you will learn about: 
- the use of nucleic acid testing and serological testing for diagnostics of COVID-19, as well as the benefits and limitations of these methods for COVID-19 diagnostics
- the effects of SARS-CoV-2 on the cardiovascular system
- the role of cardiac and inflammatory biomarkers in distinguishing the severity and prognosis of COVID-19


Read more
13 Mar, 2020
COVID-19 Related Markers and HyTest Operations

The World Health Organization (WHO) declared the Coronavirus outbreak a pandemic on Wednesday, March 11, and we are very closely following the changing situation on a daily basis. We would like to confirm to you that we are continuing to supply our products as normal.

Read more
26 Feb, 2020
New Video Published: NT-proBNP Assays and Standardization

Heart failure is a severe health problem that is characterized by an increasing prevalence and economic cost.

Read more
14 Feb, 2020
We are Sponsoring Cancer Challenge

How can we make cancer research, treatment and life with cancer better? Read more and join the contest

Read more
31 Jan, 2020
HyTest Supports Fight against COVID-19

HyTest Shanghai has decided to cancel the opening ceremony of the new premises scheduled for the end of February 2020 due to the epidemic situation in China

Read more
29 Jan, 2020
New Products! NGAL Antibodies and Antigen

NGAL (neutrophil gelatinase-associated lipocalin) is a small glycoprotein found in blood and urine. It is expressed by kidney tubular cells after kidney injury and it has been indicated as a promising biomarker of acute kidney injury. In addition, NGAL concentration is known to increase in severe infections.

We provide several mouse and rabbit derived monoclonal antibodies specific to human NGAL. In addition, we have developed a recombinant NGAL protein that can be used as a calibrator or standard in NGAL immunoassays.

Read more
26 Nov, 2019
New Product! GFAP Antibodies

Traumatic brain injuries (TBIs), including concussions, are one of the main public health concerns globally. TBI diagnosis is currently based on clinical assessment using scores such as Glasgow coma scale and computer tomography. However, scores can be compromised for various reasons and the computer tomography is less than perfect too as even in severe cases the findings can be normal.

Read more

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!